Healthcare provider profile · identity verified

Chloe Kindred

Family Practice · DAYTONA BEACH, FL · NPI 1790348191

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	495	162
Levothyroxine Sodium	Levothyroxine Sodium	411	131
Amlodipine Besylate	Amlodipine Besylate	345	118
Rosuvastatin Calcium	Rosuvastatin Calcium	319	109
Losartan Potassium	Losartan Potassium	310	104
Lisinopril	Lisinopril	270	83
Pantoprazole Sodium	Pantoprazole Sodium	162	53
Albuterol Sulfate Hfa	Albuterol Sulfate	154	43
Omeprazole	Omeprazole	147	46
Trazodone Hcl	Trazodone Hcl	147	52
Hydrochlorothiazide	Hydrochlorothiazide	145	50
Metformin Hcl	Metformin Hcl	145	49
Metoprolol Succinate	Metoprolol Succinate	142	40
Gabapentin	Gabapentin	132	41
Mounjaro	Tirzepatide	127	19
Sertraline Hcl	Sertraline Hcl	105	35
Tamsulosin Hcl	Tamsulosin Hcl	104	38
Fluticasone Propionate	Fluticasone Propionate	102	30
Metoprolol Tartrate	Metoprolol Tartrate	102	31
Simvastatin	Simvastatin	101	34
Furosemide	Furosemide	97	33
Metformin Hcl Er	Metformin Hcl	82	25
Zolpidem Tartrate	Zolpidem Tartrate	82	23
Eliquis	Apixaban	81	24
Ezetimibe	Ezetimibe	76	27
Escitalopram Oxalate	Escitalopram Oxalate	74	29
Montelukast Sodium	Montelukast Sodium	71	24
Pravastatin Sodium	Pravastatin Sodium	70	22
Alendronate Sodium	Alendronate Sodium	65	25
Jardiance	Empagliflozin	64	21
Citalopram Hbr	Citalopram Hydrobromide	63	18
Meloxicam	Meloxicam	60	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	57	22
Clopidogrel	Clopidogrel Bisulfate	56	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	21
Carvedilol	Carvedilol	50	18
Sumatriptan Succinate	Sumatriptan Succinate	49	13
Amitriptyline Hcl	Amitriptyline Hcl	48	suppressed
Famotidine	Famotidine	48	19
Allopurinol	Allopurinol	47	15
Atenolol	Atenolol	46	15
Azelastine Hcl	Azelastine Hcl	46	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	12
Ozempic	Semaglutide	45	13
Temazepam	Temazepam	44	suppressed
Bupropion Xl	Bupropion Hcl	42	14
Potassium Chloride	Potassium Chloride	42	16
Synthroid	Levothyroxine Sodium	42	13
Buspirone Hcl	Buspirone Hcl	40	14
Spironolactone	Spironolactone	40	14
Tizanidine Hcl	Tizanidine Hcl	39	11
Esomeprazole Magnesium	Esomeprazole Magnesium	38	12
Olmesartan Medoxomil	Olmesartan Medoxomil	38	15
Estradiol	Estradiol	36	15
Glimepiride	Glimepiride	35	suppressed
Duloxetine Hcl	Duloxetine Hcl	32	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	12
Venlafaxine Hcl Er	Venlafaxine Hcl	32	12
Celecoxib	Celecoxib	31	11
Fenofibrate	Fenofibrate Nanocrystallized	30	12
Lovastatin	Lovastatin	30	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	30	23
Fenofibrate	Fenofibrate	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	21
Farxiga	Dapagliflozin Propanediol	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	14
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	27	suppressed
Methylprednisolone	Methylprednisolone	26	25
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Naltrexone Hcl	Naltrexone Hcl	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Azithromycin	Azithromycin	24	17
Diclofenac Sodium	Diclofenac Sodium	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Glipizide Er	Glipizide	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Ramipril	Ramipril	22	suppressed
Valsartan	Valsartan	22	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Glipizide	Glipizide	19	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	11
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Ondansetron Odt	Ondansetron	15	11
Sucralfate	Sucralfate	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Baclofen	Baclofen	14	suppressed
Cholestyramine	Cholestyramine (With Sugar)	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Topiramate	Topiramate	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Acetazolamide	Acetazolamide	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Naproxen	Naproxen	12	suppressed
Nystatin	Nystatin	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Alprazolam	Alprazolam	11	suppressed
Dilt-Xr	Diltiazem Hcl	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Insulin Aspart Flexpen	Insulin Aspart	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error